Sheelagh Frame

Title: Sheelagh Frame: Innovator in Pharmaceutical Research

Introduction

Sheelagh Frame is a distinguished inventor based in Dundee, GB. She has made significant contributions to the field of pharmaceutical research, particularly in the development of innovative treatments for proliferative disorders. With a total of 2 patents, her work has garnered attention in the scientific community.

Latest Patents

Her latest patents include a combination of a purine-based CDK inhibitor with a tyrosine kinase inhibitor, aimed at treating proliferative disorders. This invention involves a combination comprising an ErbB inhibitor and a CDK inhibitor, or a pharmaceutically acceptable salt thereof. The specific inhibitors include roscovitine and various derivatives that have potential applications in pharmaceutical products and compositions. Another notable patent involves trisubstituted purine derivatives, which are compounds designed to treat a range of conditions, including viral disorders, stroke, and neurodegenerative disorders.

Career Highlights

Throughout her career, Sheelagh Frame has worked with prominent organizations such as Cyclacel Limited and Cancer Research Technology Limited. Her experience in these companies has allowed her to advance her research and contribute to the development of new therapeutic strategies.

Collaborations

Sheelagh has collaborated with notable colleagues, including Simon Richard Green and Peter William Sheldrake. These partnerships have further enriched her research endeavors and expanded the impact of her inventions.

Conclusion

Sheelagh Frame's innovative work in pharmaceutical research exemplifies her commitment to advancing medical science. Her patents reflect her dedication to finding effective treatments for complex health issues.